Almonertinib mesylate is an irreversible, highly selective EGFR tyrosine kinase inhibitor targeting sensitizing and T790M resistance mutations. It is widely used in non-small cell lung cancer (NSCLC) research, with applications in both in vitro biochemical assays and in vivo xenograft models to study efficacy and resistance mechanisms.
Molecular Weight:
621.75
Purity:
99.92% (May vary between batches)
CAS Number:
[2134096-06-1]
Formula:
C31H39N7O5S
Target:
EGFR
Application Notes:
Solubility: DMSO:40 mg/mL (64.33 mM)
* VAT and and shipping costs not included. Errors and price changes excepted